DiaMedica Therapeutics Inc.
DMAC
$6.05
$0.091.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.74M | -8.62M | -7.70M | -7.71M | -7.90M |
| Total Depreciation and Amortization | 11.00K | 18.00K | 3.00K | 11.00K | 11.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 961.00K | 788.00K | 611.00K | 626.00K | 278.00K |
| Change in Net Operating Assets | 3.00K | 1.26M | -513.00K | -79.00K | 1.18M |
| Cash from Operations | -7.77M | -6.55M | -7.60M | -7.15M | -6.43M |
| Capital Expenditure | -6.00K | -16.00K | -6.00K | -12.00K | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.00M | -25.75M | 8.96M | 6.63M | 5.21M |
| Cash from Investing | 8.00M | -25.77M | 8.96M | 6.62M | 5.21M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.00K | -3.00K | -2.00K | -3.00K | -3.00K |
| Issuance of Common Stock | 12.04M | 31.99M | 163.00K | 94.00K | 123.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 56.00K | -456.00K | -- | -- | -- |
| Cash from Financing | 12.09M | 31.53M | 161.00K | 91.00K | 120.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.32M | -783.00K | 1.52M | -436.00K | -1.11M |